POM Investment Strategies’s AbbVie ABBV Stock Holding History

POM Investment Strategies’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$376K	Buy	1,492 +1,396	+1,454%	+$300K	0.43%	26
2026 Q1	$20.9K	Sell	96 -182	-65%	-$40.4K	0.03%	158
2025 Q4	$63.4K	Buy	278 +267	+2,427%	+$60.8K	0.03%	57
2025 Q3	$2.55K	Buy	+11	New	+$2.24K	﹤0.01%	151
2025 Q1	–	Sell	-210	Closed	-$37.3K	–	215
2024 Q4	$37.3K	Sell	210 -111	-35%	-$20.4K	0.03%	91
2024 Q3	$63.4K	Buy	321 +113	+54%	+$21.1K	0.05%	61
2024 Q2	$35.7K	Buy	208 +1	+0.5%	+$166	0.03%	89
2024 Q1	$37.7K	Buy	207 +1	+0.5%	+$172	0.03%	75
2023 Q4	$31.9K	Buy	+206	New	+$30K	0.03%	75

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

POM Investment Strategies's ABBV Position: Q2 2026 in Review

POM Investment Strategies increased its AbbVie (ABBV) stake by 1,454% in Q2 2026, buying an estimated $300K and bringing the position to 1,492 shares worth $376K. The position accounts for 0.43% of the portfolio, ranked #26.

POM Investment Strategies first reported a position in ABBV in Q4 2023 and has held it in 9 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

POM Investment Strategies held 1,492 shares of AbbVie worth $376K as of Q2 2026.
POM Investment Strategies bought 1,396 AbbVie shares in Q2 2026, an estimated $300K.
AbbVie made up 0.43% of POM Investment Strategies's portfolio in Q2 2026, its #26 holding.
POM Investment Strategies first reported a position in AbbVie in Q4 2023 and has held it in 9 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on POM Investment Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.